240 related items for PubMed ID: 12064849
1. Linear growth and final height in patients with systemic juvenile idiopathic arthritis treated with longterm glucocorticoids.
Simon D, Fernando C, Czernichow P, Prieur AM.
J Rheumatol; 2002 Jun; 29(6):1296-300. PubMed ID: 12064849
[Abstract] [Full Text] [Related]
2. Linear growth in children suffering from juvenile idiopathic arthritis requiring steroid therapy: natural history and effects of growth hormone treatment on linear growth.
Simon D, Lucidarme N, Prieur AM, Ruiz JC, Czernichow P.
J Pediatr Endocrinol Metab; 2001 Jun; 14 Suppl 6():1483-6. PubMed ID: 11837503
[Abstract] [Full Text] [Related]
3. Attained adult height in juvenile rheumatoid arthritis with or without corticosteroid treatment.
Wang SJ, Yang YH, Lin YT, Yang CM, Chiang BL.
Clin Rheumatol; 2002 Sep; 21(5):363-8. PubMed ID: 12223982
[Abstract] [Full Text] [Related]
4. High dose, alternate day corticosteroids for systemic onset juvenile rheumatoid arthritis.
Kimura Y, Fieldston E, Devries-Vandervlugt B, Li S, Imundo L.
J Rheumatol; 2000 Aug; 27(8):2018-24. PubMed ID: 10955346
[Abstract] [Full Text] [Related]
5. Effect of long-term low-dose prednisone on height velocity and disease activity in pediatric and adolescent patients with Crohn disease.
Navarro FA, Hanauer SB, Kirschner BS.
J Pediatr Gastroenterol Nutr; 2007 Sep; 45(3):312-8. PubMed ID: 17873743
[Abstract] [Full Text] [Related]
6. Growth hormone improves height in patients with juvenile idiopathic arthritis: 4-year data of a controlled study.
Bechtold S, Ripperger P, Häfner R, Said E, Schwarz HP.
J Pediatr; 2003 Oct; 143(4):512-9. PubMed ID: 14571231
[Abstract] [Full Text] [Related]
7. Frequency of osteopenia in adolescents with early-onset juvenile idiopathic arthritis: a long-term outcome study of one hundred five patients.
Lien G, Flatø B, Haugen M, Vinje O, Sørskaar D, Dale K, Johnston V, Egeland T, Førre Ø.
Arthritis Rheum; 2003 Aug; 48(8):2214-23. PubMed ID: 12905475
[Abstract] [Full Text] [Related]
8. Children with oligoarticular juvenile idiopathic arthritis are at considerable risk for growth retardation.
Padeh S, Pinhas-Hamiel O, Zimmermann-Sloutskis D, Berkun Y.
J Pediatr; 2011 Nov; 159(5):832-837.e1-2. PubMed ID: 21621220
[Abstract] [Full Text] [Related]
9. Growth and final height after liver transplantation during childhood.
Scheenstra R, Gerver WJ, Odink RJ, van Soest H, Peeters PM, Verkade HJ, Sauer PJ.
J Pediatr Gastroenterol Nutr; 2008 Aug; 47(2):165-71. PubMed ID: 18664868
[Abstract] [Full Text] [Related]
10. Etanercept treatment improves longitudinal growth in prepubertal children with juvenile idiopathic arthritis.
Vojvodich PF, Hansen JB, Andersson U, Sävendahl L, Hagelberg S.
J Rheumatol; 2007 Dec; 34(12):2481-5. PubMed ID: 18050366
[Abstract] [Full Text] [Related]
11. Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect.
Wit JM, Rekers-Mombarg LT, Cutler GB, Crowe B, Beck TJ, Roberts K, Gill A, Chaussain JL, Frisch H, Yturriaga R, Attanasio AF.
J Pediatr; 2005 Jan; 146(1):45-53. PubMed ID: 15644821
[Abstract] [Full Text] [Related]
12. Management of growth retardation in juvenile idiopathic arthritis.
Simon D.
Horm Res; 2007 Jan; 68 Suppl 5():122-5. PubMed ID: 18174727
[Abstract] [Full Text] [Related]
13. Effect of inflammatory activity and glucocorticoid [corrected] use on nutritional variables in patients with juvenile idiopathic arthritis.
Souza L, Machado SH, Bredemeier M, Brenol JC, Xavier RM.
J Rheumatol; 2006 Mar; 33(3):601-8. PubMed ID: 16511929
[Abstract] [Full Text] [Related]
14. [Relationship between bone mineral content and growth disorders in children with juvenile idiopathic arthritis].
Górska A, Urban M, Konstantynowicz J, Bartnicka M, Chlabicz S, Górski S, Kaczmarski M.
Pol Merkur Lekarski; 2008 Mar; 24(141):227-30. PubMed ID: 18634288
[Abstract] [Full Text] [Related]
15. Final height in Swedish children with idiopathic growth hormone deficiency enrolled in KIGS treated optimally with growth hormone.
Westphal O, Lindberg A, Swedish KIGS National Board.
Acta Paediatr; 2008 Dec; 97(12):1698-706. PubMed ID: 18976357
[Abstract] [Full Text] [Related]
16. Cartilage oligomeric matrix protein in patients with juvenile idiopathic arthritis: relation to growth and disease activity.
Bjørnhart B, Juul A, Nielsen S, Zak M, Svenningsen P, Müller K.
J Rheumatol; 2009 Aug; 36(8):1749-54. PubMed ID: 19605679
[Abstract] [Full Text] [Related]
17. Follow-up of linear growth of body height in children with nephrotic syndrome.
Hung YT, Yang LY.
J Microbiol Immunol Infect; 2006 Oct; 39(5):422-5. PubMed ID: 17066206
[Abstract] [Full Text] [Related]
18. Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosis.
Lai HC, FitzSimmons SC, Allen DB, Kosorok MR, Rosenstein BJ, Campbell PW, Farrell PM.
N Engl J Med; 2000 Mar 23; 342(12):851-9. PubMed ID: 10727589
[Abstract] [Full Text] [Related]
19. Randomized, double-blind trial of deflazacort versus prednisone in juvenile chronic (or rheumatoid) arthritis: a relatively bone-sparing effect of deflazacort.
Loftus J, Allen R, Hesp R, David J, Reid DM, Wright DJ, Green JR, Reeve J, Ansell BM, Woo PM.
Pediatrics; 1991 Sep 23; 88(3):428-36. PubMed ID: 1881719
[Abstract] [Full Text] [Related]
20. Accuracy of Wallace criteria for clinical remission in juvenile idiopathic arthritis: a cohort study of 761 consecutive cases.
Lurati A, Salmaso A, Gerloni V, Gattinara M, Fantini F.
J Rheumatol; 2009 Jul 23; 36(7):1532-5. PubMed ID: 19487265
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
